Your browser doesn't support javascript.
loading
Two Rare Complications in One Patient: Acquired von Willebrand Syndrome Associated with Intracranial Plasmacytoma.
Auge, H; Yguel, C; Schmitt, E; Frotscher, B; Busby-Venner, H; Morizot, R; Moulin, C; Feugier, P; Perrot, A; Filliatre-Clement, L.
Afiliação
  • Auge H; Hematology Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.
  • Yguel C; Histopathology Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.
  • Schmitt E; Neuroradiology Department, University Hospital of Nancy, 29 Avenue du Maréchal de Lattre de Tassigny, 54035 Nancy, France.
  • Frotscher B; Hemostasis Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.
  • Busby-Venner H; Histopathology Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.
  • Morizot R; Hematology Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.
  • Moulin C; Hematology Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.
  • Feugier P; Hematology Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.
  • Perrot A; Hematology Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.
  • Filliatre-Clement L; Hematology Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.
Case Rep Hematol ; 2019: 7609308, 2019.
Article em En | MEDLINE | ID: mdl-31534805
ABSTRACT
Here, we describe a rare case of acquired von Willebrand syndrome (VWS) associated with intracranial plasmacytoma. The literature includes reports of a few cases of plasmacytoma with central nervous involvement, but none of them with acquired VWS. Diagnosis was made based on a stereotaxic intracerebral biopsy. During this biopsy, a ventriculoperitoneal shunt was established, which was complicated with abnormal bleeding. Subsequent hemostasis assessment related to hemopathy revealed acquired von Willebrand disease. The patient received induction therapy with bortezomib, thalidomide, and dexamethasone (VTD), followed by high-dose melphalan chemotherapy and autologous stem cell transplantation, and then VTD consolidation, and finally maintenance with lenalidomide. Our patient currently remains in very good partial response without neurological symptoms after 4 months of maintenance. The patient is free of progression 14 months after their original presentation.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Case Rep Hematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Case Rep Hematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França